Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gokal, R.
Right arrow Articles by Wilkinson, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gokal, R.
Right arrow Articles by Wilkinson, R
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1987) 2: 172-178
© 1987 European Renal Association-European Dialysis and Transplant Association

research-article

Multi-Centre Study on Outcome of Treatment in Patients on Continuous Ambulatory Peritoneal Dialysis and Haemodialysis

R. Gokal, R. Baillod1, S. Bogle, L. Hunt, C. Jakubowski, F. Marsh2, C. Ogg3, D. Oliver4, M. Ward5 and R Wilkinson5

Royal Infirmary(Manchester) UK 1Royal Free Hospital London, UK 2London Hospital(London) UK 3Guys hospital UK 4Churchill Hospital(Oxford) UK 5Royal Victoria Infirmary and Freeman Road Hospital(Newcastle Upon Tyne) UK

Correspondence and offprint requests to: Correspondence and offprint requests to: Dr R. Gokal, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK

In a multi-centre study by seven large renal units in the United Kingdom, the morbidity and mortality of all patients starting CAPD and haemodialysis during a 2-year period (1983–1984) has been monitored prospectively and related to reasons for choice of therapy and potential risk factors.

Over this period 338 new patients (mean age 48; range 3–77 years) started CAPD; 17% had diabetes mellitus and 25% had cerebro/cardiovascular disease. One hundred and seventy-five patients (mean age 45; range 5–73 years) started haemodialysis; 6% had diabetes mellitus and 14% had cerebro/cardiovascular disease. The Kaplan-Meier actuarial patient survival estimates at 2 years were haemodialysis 84% and CAPD 83%, whilst technique survival figures for the same period were haemodialysis 92% and CAPD .80%. Cox's regression analysis showed that cerebro/cardiovascular disease and age >60 years were most important predictors for survival in CAPD patients, in whom smoking appeared to be a significant risk factor, for permanent change of therapy to haemodialysis. The major cause of ‘drop out’ in both groups was transplantation, whilst hospitalisation was 14.9 days per patient year for CAPD and 12.8 for haemodialysis patients. Within the CAPD group a temporary change to haemodialysis (<2 months) occurred on 106 occasions (each of mean of 19 days duration), amounting to 10 days per patient year of therapy.

CAPD was used twice as often as haemodialysis for managing new patients. After 2 years hospitalisation technique and patient survival were comparable in the two groups, with cerebro/cardiovascular disease, age, and smoking being significant predictors of outcome.

Keywords: CAPD; Haemodialysis; Patient/Technique survival; Hospitalisation; Peritonitis rates; Catheter complications


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
A. G. Stack
Determinants of Modality Selection among Incident US Dialysis Patients: Results from a National Study
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1279 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. VAN BIESEN, R. C. VANHOLDER, N. VEYS, A. DHONDT, and N. H. LAMEIRE
An Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 116 - 125.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
E. F. VONESH and J. MORAN
Mortality in End-Stage Renal Disease: A Reassessment of Differencesbetween Patients Treated with Hemodialysis and Peritoneal Dialysis
J. Am. Soc. Nephrol., February 1, 1999; 10(2): 354 - 365.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.